Donna Vickery

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Thomas Powles, Katriina Peltola et al. · New England Journal of Medicine · 2024 · 111 citations

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study

Toni K. Choueiri, David F. McDermott, Jaime R. Merchan et al. · The Lancet Oncology · 2023 · 96 citations

Urology, Genitourinary Cancer, Medicine +5

Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers

Gopal Krishna, Lei Ma, Donna Vickery et al. · Antimicrobial Agents and Chemotherapy · 2009 · 54 citations · Full text

Drug Safety, Nutrition, Liquid Nutritional Supplement +10

LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study

Laurence Albigès, Brian I. Rini, Katriina Peltola et al. · Annals of Oncology · 2023 · 52 citations · Full text

Urology, Genitourinary Cancer, Medicine +5

Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers

Elizabeth S. Dodds Ashley, Jay B. Varkey, Gopal Krishna et al. · Antimicrobial Agents and Chemotherapy · 2009 · 34 citations · Full text

Drug Safety, Therapeutic Drug Monitoring, Drug Analysis +12